` 7UM (Ultimovacs ASA) vs DAX Index Comparison - Alpha Spread

U
7UM
vs
D
DAX Index

Over the past 12 months, 7UM has underperformed DAX Index, delivering a return of -46% compared to the DAX Index's +21% growth.

Stocks Performance
7UM vs DAX Index

Loading
7UM
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
7UM vs DAX Index

Performance Gap Between 7UM and GDAXI
HIDDEN
Show

Performance By Year
7UM vs DAX Index

Loading
7UM
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Ultimovacs ASA vs Peers

DAX Index
7UM
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Ultimovacs ASA
Glance View

Market Cap
36.7m EUR
Industry
Biotechnology

Ultimovacs AS operates as a pharmaceutical company. The company is headquartered in Oslo, Oslo. The company went IPO on 2019-06-03. The firm's lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase. UV1 is being developed as a therapeutic cancer vaccine which may serve as a platform for use in combination with other immuno-oncology drugs which require an ongoing T cell response for their mode of action. The firm is performing a broad clinical development program with clinical trials in Europe and the USA.

7UM Intrinsic Value
Not Available
Back to Top